Abstract
There is wide variation in the reported prevalence of cognitive impairment in people with HIV (PWH). Part of this variation may be attributable to different studies using different methods of combining neuropsychological test scores to classify participants as either cognitively impaired or unimpaired. Our aim was to determine, in a South African cohort of PWH (N = 148), (a) how much variation in reported rates was due to method used to define cognitive impairment and (b) which method correlated best with MRI biomarkers of HIV-related brain pathology. Participants completed detailed neuropsychological assessment and underwent 3 T structural MRI and diffusion tensor imaging (DTI). We used the neuropsychological data to investigate 20 different methods of determining HIV-associated cognitive impairment. We used the neuroimaging data to obtain volumes for cortical and subcortical grey matter and total white matter and DTI metrics for several white matter tracts. Applying each of the 20 methods to the cognitive dataset resulted in a wide variation (20–97%) in estimated rates of impairment. Logistic regression models showed no method was associated with HIV-related neuroimaging abnormalities as measured by structural volumes or DTI metrics. We conclude that for the population from which this sample was drawn, much of the variation in reported rates of cognitive impairment in PWH is due to the method of classification used, and that none of these methods accurately reflects biological effects of HIV in the brain. We suggest that defining HIV-associated cognitive impairment using neuropsychological test performance only is insufficient; pre-morbid functioning, co-morbidities, cognitive symptoms, and functional impairment should always be considered.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alakkas A, Ellis RJ, Watson CW-M, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C, Clifford DB, Gelman B (2019) White matter damage, neuroinflammation, and neuronal integrity in HAND. J Neurovirol 25:32–41. https://doi.org/10.1007/s13365-018-0682-9
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
Antinori A, Arendt G, Becker J, Brew B, Byrd D, Cherner M, Clifford D, Cinque P, Epstein L, Goodkin K (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799. https://doi.org/10.1212/01.WNL.0000287431.88658.8b
Arenas-Pinto A, Stöhr W, Jäger HR, Haddow L, Clarke A, Johnson M, Chen F, Winston A, Godi C, Thust S (2016) Neurocognitive function and neuroimaging markers in virologically suppressed HIV-positive patients randomized to ritonavir-boosted protease inhibitor monotherapy or standard combination ART: a cross-sectional substudy from the PIVOT trial. Clin Infect Dis 63:257–264. https://doi.org/10.1093/cid/ciw279
Bloch M, Kamminga J, Jayewardene A, Bailey M, Carberry A, Vincent T, Quan D, Maruff P, Brew B, Cysique LA (2016) A screening strategy for HIV-associated neurocognitive disorders that accurately identifies patients requiring neurological review. Clin Infect Dis 63:687–693. https://doi.org/10.1093/cid/ciw399
Campbell LM, Fennema-Notestine C, Saloner R, Hussain M, Chen A, Franklin D, Umlauf A, Ellis RJ, Collier AC, Marra CM (2020) Use of neuroimaging to inform optimal neurocognitive criteria for detecting HIV-Associated brain abnormalities. J Int Neuropsychol Soc 26:147–162. https://doi.org/10.1017/S1355617719000985
Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307–319. https://doi.org/10.1080/13803390490510031
Catani M, de Schotten MT (2012) Atlas of human brain connections. Oxford University Press
Chockanathan U, DSouza AM, Abidin AZ, Schifitto G, Wismüller A, (2019) Automated diagnosis of HIV-associated neurocognitive disorders using large-scale Granger causality analysis of resting-state functional MRI. Comput Biol Med 106:24–30. https://doi.org/10.1016/j.compbiomed.2019.01.006
Ciccarelli N (2019) Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update? Infection 1–6. https://doi.org/10.1007/s15010-019-01373-8
City of Cape Town (2013) 2011 Census Suburb Khayelitsha. http://resource.capetown.gov.za/documentcentre/Documents/Maps%20and%20statistics/2011_Census_CT_Suburb_Khayelitsha_Profile.pdf
Correia S, Lee SY, Voorn T, Tate DF, Paul RH, Zhang S, Salloway SP, Malloy PF, Laidlaw DH (2008) Quantitative tractography metrics of white matter integrity in diffusion-tensor MRI. Neuroimage 42:568–581. https://doi.org/10.1016/j.neuroimage.2008.05.022
Cysique LA, Brew BJ (2011) Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol 17:176–183. https://doi.org/10.1007/s13365-011-0021-x
Cysique LA, Heaton RK, Kamminga J, Lane T, Gates TM, Moore DM, Hubner E, Carr A, Brew BJ (2014) HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research. J Neurovirol 20:258–268. https://doi.org/10.1007/s13365-014-0242-x
De Francesco D, Underwood J, Post FA, Vera JH, Williams I, Boffito M, Memory Sachikonye M, Jane Anderson J, Mallon PWG, Winston A, Sabin CA (2016) Defining cognitive impairment in people-living-with-HIV: the POPPY study. BMC Infect Dis 16:617. https://doi.org/10.1186/s12879-016-1970-8
Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968–980. https://doi.org/10.1016/j.neuroimage.2006.01.021
Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci 97:11050–11055. https://doi.org/10.1073/pnas.200033797
Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, Van Der Kouwe A, Killiany R, Kennedy D, Klaveness S (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341–355. https://doi.org/10.1016/S0896-6273(02)00569-XGet
Gates TM, Cysique LA (2016) The chronicity of HIV infection should drive the research strategy of neuroHIV treatment studies: A critical review. CNS Drugs 30:53–69. https://doi.org/10.1007/s40263-015-0302-7
Gisslén M, Price RW, Nilsson S (2011) The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis. https://doi.org/10.1186/1471-2334-11-356
Grant I (2008) Neurocognitive disturbances in HIV. Int Rev Psychiatry 20:33–47. https://doi.org/10.1080/09540260701877894
Grant, I., Franklin, D. R., Deutsch, R., Woods, S. P., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J., & Collier, A. C. (2014). Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 82(23):2055–2062. https://doi.org/10.1212/WNL.0000000000000492
Heaps JM, Joska J, Hoare J, Ortega M, Agrawal A, Seedat S, Ances BM, Stein DJ, Paul R (2012) Neuroimaging markers of human immunodeficiency virus infection in South Africa. J Neurovirol 18:151–156. https://doi.org/10.1007/s13365-012-0090-5
Heaps JM, Sithinamsuwan P, Paul R, Lerdlum S, Pothisri M, Clifford D, Tipsuk S, Catella S, Busovaca E, Fletcher JL (2015) Association between brain volumes and HAND in cART-naive HIV+ individuals from Thailand. J Neurovirol 21:105–112. https://doi.org/10.1007/s13365-014-0309-8
Heaton RK, Cysique LA, ** H, Shi C, Yu X, Letendre S, Franklin DR, Ake C, Vigil O, Atkinson JH (2008) Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol 14:536–549. https://doi.org/10.1080/13550280802378880
Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, LeBlanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Rivera Mindt M, Taylor MJ, Marcotte TD, Atkinson H, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3–16. https://doi.org/10.1007/s13365-010-0006-1
Huizenga HM, Agelink van Rentergem JA, Grasman RP, Muslimovic D, Schmand B (2016) Normative comparisons for large neuropsychological test batteries: User-friendly and sensitive solutions to minimize familywise false positives. J Clin Exp Neuropsychol 38:611–629. https://doi.org/10.1080/13803395.2015.1132299
Huizenga HM, Smeding H, Grasman RP, Schmand B (2007) Multivariate normative comparisons. Neuropsychologia 45:2534–2542. https://doi.org/10.1016/j.neuropsychologia.2007.03.011
Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM (2012) Fsl Neuroimage 62:782–790. https://doi.org/10.1016/j.neuroimage.2011.09.015
Jenkinson M, Smith S (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5:143–156. https://doi.org/10.1016/S1361-8415(01)00036-6
Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ (2010) Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. J Neurovirol 16:101–114. https://doi.org/10.3109/13550281003682513
Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, Paul RH, Stein DJ, Flisher AJ (2011) Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav 15:1197–1203. https://doi.org/10.1007/s10461-010-9744-6
Kamminga J, Bloch M, Vincent T, Carberry A, Brew BJ, Cysique LA (2017) Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure. J Clin Exp Neuropsychol 39:753–767. https://doi.org/10.1080/13803395.2016.1263282
Kelly CM, van Oosterhout JJ, Ngwalo C, Stewart RC, Benjamin L, Robertson KR, Khoo S, Allain TJ, Solomon T (2014) HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study. PLoS One 9. https://doi.org/10.1371/journal.pone.0098962
Leemans A, Jones DK (2009) The B-matrix must be rotated when correcting for subject motion in DTI data. Magnetic Resonance in Medicine: an Official Journal of the International Society for Magnetic Resonance in Medicine 61:1336–1349. https://doi.org/10.1002/mrm.21890
Leite SC, Corrêa DG, Doring TM, Kubo TT, Netto TM, Ferracini R, Ventura N, Bahia PR, Gasparetto EL (2013) Diffusion tensor MRI evaluation of the corona radiata, cingulate gyri, and corpus callosum in HIV patients. J Magn Reson Imaging 38:1488–1493. https://doi.org/10.1002/jmri.24129
Lotze M, Domin M, Schmidt CO, Hosten N, Grabe HJ, Neumann N (2020) Income is associated with hippocampal/amygdala and education with cingulate cortex grey matter volume. Sci Rep 10:18786. https://doi.org/10.1038/s41598-020-75809-9
McDonnell J, Haddow L, Daskalopoulou M, Lampe F, Speakman A, Gilson R, Phillips A, Sherr L, Wayal S, Harrison J (2014) Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men. J Acquir Immune Defic Syndr (1999) 67:120
Meyer A-CL, Boscardin WJ, Kwasa JK, Price RW (2013) Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power. Neuroepidemiology 41:208–216. https://doi.org/10.1159/000354629
Milanini B, Robert P, Bahemana E, Adamu Y, Kiweewa F, Langat R, Owuoth J, Allen E, Polyak C, Julie A (2018) Limitations of the International HIV Dementia Scale in the current era. AIDS (London, England) 32:2477. https://doi.org/10.1097/QAD.0000000000001968
Mori S, Van Zijl PC (2002) Fiber tracking: principles and strategies–a technical review. NMR in Biomedicine: an International Journal Devoted to the Development and Application of Magnetic Resonance in Vivo 15:468–480. https://doi.org/10.1002/nbm.781
Nightingale S, Winston A, Letendre S, Michael BD, McArthur JC, Khoo S, Solomon T (2014) Controversies in HIV-associated neurocognitive disorders. Lancet Neurol 13:1139–1151. https://doi.org/10.1016/S1474-4422(14)70137-1
Oishi K, Faria AV, Van Zijl PC, Mori S (2010) MRI atlas of human white matter. Academic Press
Ortega M, Heaps JM, Joska J, Vaida F, Seedat S, Stein DJ, Paul R, Ances BM (2013) HIV clades B and C are associated with reduced brain volumetrics. J Neurovirol 19:479–487. https://doi.org/10.1007/s13365-013-0202-x
Paul RH, Joska JA, Woods C, Seedat S, Engelbrecht S, Hoare J, Heaps J, Valcour V, Ances B, Baker LM (2014) Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease. J Neurovirol 20:627–635. https://doi.org/10.1007/s13365-014-0293-z
Paul RH, Phillips S, Hoare J, Laidlaw DH, Cabeen R, Olbricht GR, Su Y, Stein DJ, Engelbrecht S, Seedat S (2017) Neuroimaging abnormalities in clade C HIV are independent of Tat genetic diversity. J Neurovirol 23:319–328. https://doi.org/10.1007/s13365-016-0503-y
Phillips NJ, Hoare J, Stein DJ, Myer L, Zar HJ, Thomas KG (2018) HIV-associated cognitive disorders in perinatally infected children and adolescents: a novel composite cognitive domains score. AIDS Care 30:8–16. https://doi.org/10.1080/09540121.2018.1466982
Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, Ragin A, Levine A, Miller E (2016) Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology 86:334–340. https://doi.org/10.1212/WNL.0000000000002277
Saloner R, Cysique LA (2017) HIV-associated neurocognitive disorders: a global perspective. J Int Neuropsychol Soc 23:860–869. https://doi.org/10.1017/S1355617717001102
Schouten J, Su T, Wit FW, Kootstra NA, Caan MW, Geurtsen GJ, Schmand BA, Stolte IG, Prins M, Majoie CB (2016) Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy. AIDS 30:1027–1038. https://doi.org/10.1097/QAD.0000000000001017
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22–33.
Smit W, de Lannoy A, Dover RV, Lambert EV, Levitt N, Watson V (2016) Making unhealthy places: the built environment and non-communicable diseases in Khayelitsha, Cape Town. Health Place 39:196–203. https://doi.org/10.1016/j.healthplace.2016.04.006
Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143–155. https://doi.org/10.1002/hbm.10062
Spies G, Ahmed-Leitao F, Fennema-Notestine C, Cherner M, Seedat S (2016) Effects of HIV and childhood trauma on brain morphometry and neurocognitive function. J Neurovirol 22:149–158. https://doi.org/10.1007/s13365-015-0379-2
Statistics South Africa (2019) National Poverty Lines. http://www.statssa.gov.za/publications/P03101/P031012019.pdf
Stebbins GT, Smith CA, Bartt RE, Kessler HA, Adeyemi OM, Martin E, Cox JL, Bammer R, Moseley ME (2007) HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study. J Acquir Immune Defic Syndr 46(5):564–573. https://doi.org/10.1097/QAI.0b013e318159d807
Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, Portegies P, Caan MW, Reiss P, Majoie CB (2015) Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection. AIDs 29(5):547–557. https://doi.org/10.1097/QAD.0000000000000573
Tierney SM, Sheppard DP, Kordovski VM, Faytell MP, Avci G, Woods SP (2017) A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders. J Neurovirol 23:404–421. https://doi.org/10.1007/s13365-016-0510-z
Torti C, Focà E, Cesana BM, Lescure FX (2011) Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction? BMC Med 9:138. https://doi.org/10.1186/1741-7015-9-138
Underwood J, Cole JH, Caan M, De Francesco D, Leech R, van Zoest RA, Su T, Geurtsen GJ, Schmand BA, Portegies P (2017) Gray and white matter abnormalities in treated human immunodeficiency virus disease and their relationship to cognitive function. Clin Infect Dis 65:422–432. https://doi.org/10.1093/cid/cix301
Underwood J, De Francesco D, Cole JH, Caan MWA, van Zoest RA, Schmand BA, Sharp DJ, Sabin CA, Reiss P, Winston A, Collaboration TC-miRtA, Pharmacokinetic Clinical Observations in People Over Fifty Study Group (2019) Validation of a novel multivariate method of defining HIV-associated cognitive impairment. Open Forum Infect Dis. https://doi.org/10.1093/ofid/ofz198
Underwood J, De Francesco D, Leech R, Sabin CA, Winston A, The Co-morBidity in Relation to AIDS Collaboration, The Pharmacokinetic Clinical Observations in People Over Fifty Study Group (2018) Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment. PLoS One 13:e0194760. https://doi.org/10.1371/journal.pone.0194760
Vilagut G, Forero CG, Barbaglia G, Alonso J (2016) Screening for depression in the general population with the Center for Epidemiologic Studies Depression (CES-D): a systematic review with meta-analysis. PLoS One 11:e0155431. https://doi.org/10.1371/journal.pone.0155431
Wang Y, Liu M, Lu Q, Farrell M, Lappin JM, Shi J, Lu L, Bao Y (2020) Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis. Neurology. https://doi.org/10.1212/WNL.0000000000010752
Wang Z, Molsberry SA, Cheng Y, Kingsley L, Levine AJ, Martin E, Munro CA, Ragin A, Rubin LH, Sacktor N (2019) Cross-sectional analysis of cognitive function using multivariate normative comparisons in men with HIV disease. AIDS 33:2115–2124. https://doi.org/10.1097/QAD.0000000000002312
Watson CW-M, Sundermann EE, Hussain MA, Umlauf A, Thames AD, Moore RC, Letendre SL, Jeste DV, Morgan EE, Moore DJ (2019) Effects of trauma, economic hardship, and stress on neurocognition and everyday function in HIV. Health Psychol 38:33. https://doi.org/10.1037/hea0000688
Winston A, Spudich S (2020) Cognitive disorders in people living with HIV. Lancet HIV 7:e504–e513
Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26:759–778. https://doi.org/10.1080/13803390490509565
Wright EJ, Grund B, Cysique LA, Robertson K, Brew BJ, Collins G, Shlay J, Winston A, Read T, Price RW (2015) Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med 16:97–108. https://doi.org/10.1111/hiv.12238
Yakasai AM, Gudaji MI, Muhammad H, Ibrahim A, Owolabi LF, Ibrahim DA, Babashani M, Mi**yawa MS, Borodo MM, Ogun AS (2015) Prevalence and correlates of HIV-associated neurocognitive disorders (HAND) in Northwestern Nigeria. Neurol Res Int 2015:1–9. https://doi.org/10.1155/2015/486960
Yaple ZA, Yu R (2020) Functional and structural brain correlates of socioeconomic status. Cereb Cortex 30:181–196. https://doi.org/10.1093/cercor/bhz080
Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, Gerig G (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31:1116–1128. https://doi.org/10.1016/j.neuroimage.2006.01.015
Yusuf AJ, Hassan A, Mamman AI, Muktar HM, Suleiman AM, Baiyewu O (2017) Prevalence of HIV-associated neurocognitive disorder (HAND) among patients attending a tertiary health facility in Northern Nigeria. Journal of the International Association of Providers of AIDS Care (JIAPAC) 16:48–55. https://doi.org/10.1177/2325957414553839
Zhang H, Avants BB, Yushkevich PA, Woo JH, Wang S, McCluskey LF, Elman LB, Melhem ER, Gee JC (2007) High-dimensional spatial normalization of diffusion tensor images improves the detection of white matter differences: an example study using amyotrophic lateral sclerosis. IEEE Trans Med Imaging 26:1585–1597. https://doi.org/10.1109/TMI.2007.906784
Zhang H, Yushkevich PA, Alexander DC, Gee JC (2006) Deformable registration of diffusion tensor MR images with explicit orientation optimization. Med Image Anal 10:764–785. https://doi.org/10.1016/j.media.2006.06.004
Zhang S, Demiralp C, Laidlaw DH (2003) Visualizing diffusion tensor MR images using streamtubes and streamsurfaces. IEEE Trans Vis Comput Graph 9:454–462. https://doi.org/10.1109/TVCG.2003.1260740
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dreyer, A.J., Nightingale, S., Heaps-Woodruff, J. et al. Rates of cognitive impairment in a South African cohort of people with HIV: variation by definitional criteria and lack of association with neuroimaging biomarkers. J. Neurovirol. 27, 579–594 (2021). https://doi.org/10.1007/s13365-021-00993-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-021-00993-x